4.7 Article

A 3D-printed microfluidic gradient generator with integrated photonic silicon sensors for rapid antimicrobial susceptibility testing

期刊

LAB ON A CHIP
卷 22, 期 24, 页码 4950-4961

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/d2lc00640e

关键词

-

资金

  1. German Research Foundation (DFG) [346772917]
  2. VolkswagenStiftung
  3. DFG [SCHE 279/32-2]
  4. DFG - University of Augsburg

向作者/读者索取更多资源

With the rise of antimicrobial resistance, there is an urgent need for rapid point-of-care antimicrobial susceptibility testing (AST) diagnostics. This study introduces a 3D-printed microfluidic gradient generator that can automatically produce dilution series of antimicrobials for testing. By integrating photonic silicon chips, the researchers were able to track bacterial behavior and growth in real-time. The assay successfully determined the minimum inhibitory concentration within less than 90 minutes.
With antimicrobial resistance becoming a major threat to healthcare settings around the world, there is a paramount need for rapid point-of-care antimicrobial susceptibility testing (AST) diagnostics. Unfortunately, most currently available clinical AST tools are lengthy, laborious, or are simply inappropriate for point-of-care testing. Herein, we design a 3D-printed microfluidic gradient generator that automatically produces two-fold dilution series of clinically relevant antimicrobials. We first establish the compatibility of these generators for classical AST (i.e., broth microdilution) and then extend their application to include a complete on-chip label-free and phenotypic AST. This is accomplished by the integration of photonic silicon chips, which provide a preferential surface for microbial colonization and allow optical tracking of bacterial behavior and growth at a solid-liquid interface in real-time by phase shift reflectometric interference spectroscopic measurements (PRISM). Using Escherichia coli and ciprofloxacin as a model pathogen-drug combination, we successfully determine the minimum inhibitory concentration within less than 90 minutes. This gradient generator-based PRISM assay provides an integrated AST device that is viable for convenient point-of-care testing and offers a promising and most importantly, rapid alternative to current clinical practices, which extend to 8-24 h.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据